Israel Discount Bank of New York’s Teva Pharmaceuticals TEVA Stock Holding History

Israel Discount Bank of New York’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-400	Closed	-$7K	–	414
2018 Q1	$7K	Hold	400	–	–	﹤0.01%	395
2017 Q4	$8K	Hold	400	–	–	0.01%	398
2017 Q3	$7K	Hold	400	–	–	0.01%	401
2017 Q2	$13K	Hold	400	–	–	0.01%	382
2017 Q1	$13K	Sell	400 -1,625	-80%	-$55.5K	0.01%	392
2016 Q4	$73K	Buy	+2,025	New	+$80.8K	0.07%	188

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Israel Discount Bank of New York's TEVA Position: Q2 2018 in Review

Israel Discount Bank of New York sold out of Teva Pharmaceuticals (TEVA) in Q2 2018, closing a stake of 400 shares — an estimated $7K sold.

Israel Discount Bank of New York first reported a position in TEVA in Q4 2016 and held it in 6 quarters. The position peaked at $73K in Q4 2016. 540 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

Israel Discount Bank of New York reported no remaining Teva Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
Israel Discount Bank of New York sold 400 Teva Pharmaceuticals shares in Q2 2018, an estimated $7K.
Israel Discount Bank of New York first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 6 quarters.
Israel Discount Bank of New York's Teva Pharmaceuticals position peaked at $73K in Q4 2016.
540 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2018.

Based on Israel Discount Bank of New York's 13F filing for Q2 2018, filed 1 Aug 2018.